Profiling Leucocyte Subsets in Tuberculosis-Diabetes Co-Morbidity

Immunology - United Kingdom
doi 10.1111/imm.12496
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tuberculosis-Diabetes Co-Morbidity Is Characterized by Heightened Systemic Levels of Circulating Angiogenic Factors

Journal of Infection
Infectious DiseasesMicrobiology
2017English

Study of Hypertensive Subjects With Diabetes as Co-Morbidity

International Journal of Research in Medical Sciences
2017English

The Role of Co-Morbidity in the Selection of Antidiabetic Pharmacotherapy in Type-2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

METFORMIN INDUCED AUTOPHAGY IN DIABETES MELLITUS – TUBERCULOSIS CO-INFECTION PATIENTS: A Case Study

Indian Journal of Tuberculosis
Infectious Diseases
2019English

Endobronchial Tuberculosis: Histopathological Subsets and Microbiological Results

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2012English

Immunohistochemical Analysis of Leucocyte Subsets in the Sinonasal Mucosa of Cats With Upper Respiratory Tract Aspergillosis

Journal of Comparative Pathology
Forensic MedicinePathologyVeterinary
2016English

Microarray Analysis of Human Leucocyte Subsets: The Advantages of Positive Selection and Rapid Purification

BMC Genomics
BiotechnologyGenetics
2007English

Psychiatric Co - Morbidity in Persons With Hansen’s Disease

Journal of Evidence Based Medicine and Healthcare
2015English

Diabetes and Tuberculosis

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy